Seeking Alpha

BioTime, Inc (BTX)

  • SA Editor Mike Taylor | Send Message 8 May

    Big biotech week coming: $PTX PDUFA, $CLDN $BTX $ENDP $INO $MSLP reports, ASCO season -- what else? $IBB
      • Seattle Contributor | Send Message 7 May

        BioTime - Not Just Another Biotechnology Company - But Is That Good Or Bad? $BTX
          • EXPstocktrader | Send Message 6 Apr

            BioTime - Leading The Charge In Regenerative Medicine, Next Gen Cancer Diagnostics, Stem Cells And... $BTX
              • EXPstocktrader | Send Message 25 Mar

                A Few Stocks To Accumulate $BTX, $SRNE, $KPTI
                  • csymalla | Send Message 23 Mar

                    opportunity to make quick 10% shorting $BTX at this point?
                    Reply (1)
                    • csymalla | Send Message 24 Mar
                      : Well, that would have been a quick 10% loss.
                      • JMY Investments | Send Message 26 Jan

                        BioTime, Inc.: Following The Smart Money $BTX
                          • | Send Message 15 Jan

                            I like what is going on with $BTX. They got a new COO who was a executive from Shire so I think 2015 could be a great year for $BTX.
                              • Jim Van Meerten | Send Message 13 Jan

                                $BTX - 96% Barchart technical buy signals - 15 new highs and up 41.96% in the last month - Relaitve Strength Index 73.03%
                                  • EXPstocktrader | Send Message 15 Dec 2014

                                    Former Shire CEO joins the $BTX board; Setting up is the Regenerative Medicine Revolution
                                      • Ian C. Clift | Send Message 4 Dec 2014
                                          Visit Seeking Alpha's
                                          BTX vs. ETF Alternatives
                                          Company Description
                                          BioTime Inc is a biotechnology company. The Company is engaged in the biomedical research and product development in regenerative medicine including human embryonic stem cell and induced pluripotent stem cell technology.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States